arrow
E

Elena Hartmann

university of wuerzburg
H指数:38
被引数:8,429

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

演进至七难治性骨髓瘤涉及CD38、BCMA和GPRC5D的顺序性丢失

Leukemia
IF13.4
2026-02-170
OAAI
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma

在淋巴瘤中,适配CAR的共表达在单个和双重抗原丢失后仍能保持CAR T细胞的疗效

2025-10-240
OAAI
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma

血浆置换促进可溶性BCMA清除,并有助于逆转多发性骨髓瘤对BCMA免疫疗法的原发耐药。

Leukemia
IF13.4
2025-09-100
OAAI
World first hybrid neuroendocrine cell line sharing properties of NET G3 and dedifferentiated NEC

世界首个兼具NET G3和去分化的NEC特性的杂交神经内分泌细胞系

2025-09-010
PRE
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target

整合多组学揭示CLL中调节性及耗竭性T细胞景观,并鉴定出galectin-9作为免疫治疗靶点

2025-08-070
OA
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany

WERA癌症中心矩阵: 德国大部分农村地区患者获得精确肿瘤学的战略管理

2024-08-010
OAAI
Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape
2022-10-2015
OAAI